Rocket One (RKTO) Current Assets (2017 - 2026)
Rocket One's (RKTO) quarterly Current Assets came in at $8.6 million in Q2 2026, down 14.64% year-over-year from $10.1 million in Q2 2025, and up 76.65% quarter-over-quarter from $4.9 million in Q1 2026.
Analysis
Rocket One (RKTO) Current Assets (2017 - 2026) Analysis & Trends
Rocket One has disclosed Current Assets across 10 years of filings, most recently posting $8.6 million for Q2 2026.
- In Q2 2026, Current Assets fell 14.64% year-over-year to $8.6 million; the TTM figure through Jun 2026 stood at $8.6 million (down 14.64% YoY), while the FY2025 annual figure was $6.9 million, down 10.23% from the prior year.
- Current Assets came in at $8.6 million for Q2 2026 at Rocket One, up from $4.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $14.4 million in Q1 2023 to a low of $4.9 million in Q1 2026.
- Average Current Assets over 5 years is $9.7 million, with a median of $9.3 million recorded in 2022.
- Year-over-year, Current Assets soared 68.24% in 2023 and slumped 60.49% in 2026.
- Over 5 years, Current Assets stood at $7.7 million in 2022, then jumped by 31.66% to $10.2 million in 2023, then dropped by 24.68% to $7.6 million in 2024, then declined by 10.23% to $6.9 million in 2025, then advanced by 25.04% to $8.6 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $8.6 million in Q2 2026, $4.9 million in Q1 2026, and $6.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 4.74 Bn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 8.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.58 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 6.86 Mn |
| Sep 30, 2025 | 8.92 Mn |
| Jun 30, 2025 | 10.05 Mn |
| Mar 31, 2025 | 12.29 Mn |
| Dec 31, 2024 | 7.64 Mn |
| Sep 30, 2024 | 8.68 Mn |
| Jun 30, 2024 | 10.49 Mn |
| Mar 31, 2024 | 9.02 Mn |
| Dec 31, 2023 | 10.15 Mn |
| Sep 30, 2023 | 12.87 Mn |
| Jun 30, 2023 | 12.79 Mn |
| Mar 31, 2023 | 14.36 Mn |
| Dec 31, 2022 | 7.71 Mn |
| Sep 30, 2022 | 9.51 Mn |
| Jun 30, 2022 | 11.86 Mn |
| Mar 31, 2022 | 8.54 Mn |
| Dec 31, 2021 | 10.58 Mn |
| Sep 30, 2021 | 14.78 Mn |